OTC •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/04/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization2,885.44 mln
Float280 mln
Earnings Date08/12/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.83
Likely reliable
1-Year Forecast
15.00
Transformational upside
Relative Strength
82
/ 100
Strongly outperforming
Debt / Equity
1.01
Elevated leverage
Pre-Tax Margin
1%
Break-even
Business Description
Curaleaf Holdings is a cannabis company operating across the United States and several international markets, including Australia, New Zealand, the United Kingdom, and multiple European countries. The company grows, processes, and sells cannabis products through both its own retail locations and wholesale partnerships, serving customers who use cannabis for medical purposes as well as general adult consumers. Headquartered in Stamford, Connecticut, Curaleaf also runs a medical cannabis clinic and holds a pharmacy license.